JonathanBrianHauptmanMD

Diabetes, Lipid Metabolism

Physician

Dr. Hauptman is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Dr. Jonathan Hauptman is an Endocrinology specialist situated in Ridgewood, New Jersey. His subspecialties are Diabetes and Lipid Metabolism. His education includes a residency in Internal Medicine at Nassau University Medical Center, a fellowship in Endocrinology, Diabetes, and Metabolism at Rutgers New Jersey Medical School, and he is class of 1978 alumnus at Icahn School of Medicine at Mount Sinai. Dr. Hauptman has published notable research including "Orlistat in the long-term treatment of obesity in primary care settings," and "Unimolecular Dual Incretins Maximize Metabolic Benefits in Rodents, Monkeys, and Humans," both of which have been frequently cited by other publications.

Rutgers Health/New Jersey Medical SchoolFellowship, Endocrinology, Diabetes, and Metabolism, 1981 - 1983
Nassau University Medical CenterResidency, Internal Medicine, 1978 - 1981
Icahn School of Medicine at Mount SinaiClass of 1978

PubMed

485 citations
Unimolecular Dual Incretins Maximize Metabolic Benefits in Rodents, Monkeys, and Humans
Brian Finan, Tao Ma, Nickki Ottaway, Timo D. Müller, Kirk M. Habegger
Science Translational Medicine. 2013-10-30
247 citations
Orlistat in the long-term treatment of obesity in primary care settings.
Jonathan Hauptman, Charles P. Lucas, Mark Boldrin, Harry Collins, Karen R. Segal
Archives of Family Medicine. 2000-02-01